Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis

Critical Care Medicine

Volumn 34, Issue 3, 2006, Pages 778-784

  Bauhofer, Artur ^a   Lorenz, Wilfried ^a   Kohlert, Frank ^a   Torossian, Alexander ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Clinic modeling randomized trial; Cytokines; Hemorrhage; Mortality; Rat sepsis model; Two hit model

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PERITONITIS; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EXPERIMENTAL INFECTION; INFECTION COMPLICATION; INFECTION PREVENTION; LEUKOCYTE COUNT; MALE; MEDICAL ASSESSMENT; NEUTROPHIL COUNT; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ANIMALS; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMORRHAGE; INFLAMMATION; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS; SURVIVAL ANALYSIS;

EID: 33644588161     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000201900.01000.6B     Document Type: Article

References (44)

1. Nichols RL, Smith JW, Klein DB, et al: Risk of infection after penetrating abdominal trauma. N Engl J Med 1984; 311:1065-1070
2. Chaudry IH, Ayala A: Mechanism of increased susceptibility to infection following hemorrhage. Am J Surg 1993; 165:59S-67S
3. Livingston DH, Malangoni MA: An experimental study of susceptibility to infection after hemorrhagic shock. Surg Gynecol Obstet 1989; 168:138-142
4. Esrig BC, Frazee L, Stephenson SF, et al: The predisposition to infection following hemorrhagic shock. Surg Gynecol Obstet 1977; 144:915-917
5. Hartung T, Volk HD, Wendel A: G-CSF an anti-inflammatory cytokine. J Endotoxin Res 1995; 2:195-201
6. Zhang P, Bagby GJ, Stoltz DA, et al: Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Crit Care Med 1998; 26:315-321
7. Sheibani N, Grabowski EF, Schoenfeld DA, et al: Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice. Crit Care Med 2004; 32:2274-2278
8. Hierholzer C, Kelly E, Tsukada K, et al: Hemorrhagic shock induces G-CSF expression in bronchial epithelium. Am J Physiol 1997; 273:L1058-L1064
9. Barroso-Aranda J, Schmid-Schonbein GW, Zweifach BW, et al: Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res 1988; 63:437-447
10. Spain DA, Kawabe T, Keelan PC, et al: Decreased alpha-adrenergic response in the intestinal microcirculation after "two-hit" hemorrhage/resuscitation and bacteremia. J Surg Res 1999; 84:180-185
11. Diehl KH, Hull R, Morton D, et al: A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 2001; 21:15-23
12. Hess ML, Warner M, Okabe E: Hemorrhagic shock. In: Handbook of Shock and Trauma. Altura BM (Ed). New York, Raven Press, 1983, pp 1-393
13. Bauhofer A, Lorenz W, Celik I, et al: Haematopoetic cytokines, G-CSF and abdominal surgery. In: Cytokines and the Abdominal Surgeon. Schein M, Wise L (Eds). Austin, TX, Landes Bioscience, 1998, pp 117-141
14. Bauhofer A, Torossian A, Lorenz W, et al: Lucerne Study Group: Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regime: evaluation in rats with polymicrobial peritonitis. World J Surg 2004; 28:834-844
15. Henderson RA, Whitehurst ME, Morgan KR, et al: Reduced oxygen consumption precedes the drop in body core temperature caused by hemorrhage in rats. Shock 2000; 13:320-324
16. Lorenz W, Reimund K-P, Weitzel F, et al: Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 1994; 116:925-934
17. Bauhofer A, Stinner B, Kohlert F, et al: Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection. Br J Surg 2002; 89:1457-1463
18. Siegling A, Lehmann M, Platzer C, et al: A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Meth 1994; 177:23-28
19. Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials. Littelton, MA, PSG Publishing, 1985
20. Davis KA, Fabian TC, Ragsdale DN, et al: Granulocyte colony-stimulating factor and neutrophil-related changes in local host defense during recovery from shock and intraabdominal sepsis. Surgery 1999; 126: 305-313
21. Hierholzer C, Kelly E, Billiar TR, et al: Granulocyte colony-stimulating factor (G-CSF) production and neutrophil activation in hemorrhagic shock. Shock 1996; 5:42
22. Kale IT, Kuzu MA, Berkem H, et al: The presence of hemorrhagic shock increases the rate of bacterial translocation in blunt abdominal trauma. J Trauma 1998; 44:171-174
23. Hensler T, Hecker H, Heeg K, et al: Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 1997; 65:2283-2291
24. Shurin MR, Kusnecov A, Hamill E, et al: Stress-induced alteration of polymorphonuclear leukocyte function in rats. Brain Behav Immun 1994; 8:163-169
25. Ayala A, Wang P, Ba ZF, et al: Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 1991; 260:R167-R171
26. Martin C, Boisson C, Haccoun M, et al: Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997; 25:1813-1819
27. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993; 218:769-776
28. Stephan RN, Kupper TS, Geha AS, et al: Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 1987; 122:62-68
29. Molloy RG, Mannick JA, Rodrick ML: Cytokines, sepsis and immunomodulation. Br J Surg 1993; 80:289-297
30. Fuchs D, Malkovsky M, Reibnegger G, et al: Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol Lett 1989; 23:103-108
31. Kalyanaraman M, Heidemann SM, Sarnaik AP: Macrophage inflammatory protein-2 predicts acute lung injury in endotoxemia. J Investig Med 1998; 46:275-278
32. Torossian A, Rühlmann S, Middeke M, et al: Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte-colony stimulating factor. Anesthesiology 2003; 99:1087-1092
33. de Waal Malefyt R, Abrams J, Bennett B, et al: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-1220
34. Johnston PA, Selkurt EE: Effect of hemorrhagic shock on renal release of prostaglandin E. Am J Physiol 1976; 230:831-838
35. Ayala A, Chaudry IH: Dietary n-3 polyunsaturated fatty acid modulation of immune cell function before or after trauma. Nutrition 1995; 11:1-11
36. Gough A, Clapperton M, Rolando N, et al: Randomised placebo controlled trial of granulocyte colony-stimulating factor in diabetic foot infection. Lancet 1997; 350: 855-859
37. de Lalla F, Pellizzer G, Strazzabosco M, et al: Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 2001; 45:1094-1098
38. Yonem A, Cakir B, Guler S, et al: Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes Obes Metab 2001; 3:332-337
39. Stephens DP, Fisher DA, Currie BJ: An audit of the use of granulocyte colony-stimulating factor in septic shock. Intern Med J 2002; 32:143-148
40. Nelson S, Heyder AM, Stone J, et al: A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia. J Infect Dis 2000; 182: 970-973
41. Root RK, Marrie TJ, Lodato RF: A multicenter, double-blind, placebo-controlled study of the use of filgrastim on patients hospitalized with pneumonia and severe sepsis. Crit Care Med 2003; 31:367-373
42. Schaefer H, Engert A, Grass G, et al: Perioperative granulocyte colony-stimulating factor does not prevent severe infections in patients undergoing esophagectomy for esophageal cancer: A randomized placebo-controlled clinical trial. Ann Surg 2004; 240: 68-75
43. Bauhofer A, Lorenz W, Stinner B, et al: Lucerne Group for Consensus-Assisted Development of the Study Protocol on Prevention of Abdominal Sepsis: Example G-CSF. Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimum recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by consensus of an international study group. Part 2: Design of the study. Inflamm Res 2001; 50:187-205
44. Bauhofer A, Torossian A, Plaul U, et al: Improving the outcome of high risk patients with colorectal cancer surgery by G-CSF prophylaxis. Surg Infect 2005; 6:156